Our QA system is founded on the guidelines for good clinical practices (GLP), Good laboratory practices (GLP), and FDA principals for quality systems. INTERVEIN is accredited with NABL (ISO 15189) and college of American pathologies (CAP). The QA department helps our central lab to achieve the highest levels of client of satisfaction and subject safety, while maintaining compliance and audit readiness.
Detailed standard operating (SOPs) governing all critical paths are in effect. Our record keeping practices, both paper and electronic are fully compliant with GCP and our electronic are fully compliant with GCP, and our electronic systems comply with FDA 21 CFR part 11.
Precision and reproducibility of analytical data are ensured by regular monitoring of internal QA results as well as by participation in a number of national and international external quality assurance schemes.
Quality control procedures are in place to ensure continuous accurate data recording. In addition, comprehensive internal audits of all departments are conducted annually by our independent quality assurance group.